Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT04245514 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04245514
- Sponsor
- Swiss Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-15
- Primary completion
- 2026-07-16
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.